Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy

Cancer Science
Shingo MiyamotoEisuke Mekada

Abstract

HB-EGF, a member of the EGF family of growth factors, exerts its biological activity through activation of the EGFR and other ErbB receptors. HB-EGF participates in diverse biological processes, including heart development and maintenance, skin wound healing, eyelid formation, blastocyst implantation, progression of atherosclerosis and tumor formation, through the activation of signaling molecules downstream of ErbB receptors and interactions with molecules associated with HB-EGF. Recent studies have indicated that HB-EGF gene expression is significantly elevated in many human cancers and its expression level in a number of cancer-derived cell lines is much higher than those of other EGFR ligands. Several lines of evidence have indicated that HB-EGF plays a key role in the acquisition of malignant phenotypes, such as tumorigenicity, invasion, metastasis and resistance to chemotherapy. Studies in vitro and in vivo have indicated that HB-EGF expression is essential for tumor formation of cancer-derived cell lines. CRM197, a specific inhibitor of HB-EGF, and an antibody against HB-EGF are both able to inhibit tumor growth in nude mice. These results indicate that HB-EGF is a promising target for cancer therapy, and that the develo...Continue Reading

References

Sep 1, 1971·Nature: New Biology·T UchidaA M Pappenheimer
Nov 23, 1995·Nature·D Meyer, C Birchmeier
Aug 15, 1994·Biochemical and Biophysical Research Communications·M S KobrinM Korc
Jan 13, 1998·Biochimica Et Biophysica Acta·G Raab, M Klagsbrun
Mar 21, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D J Riese, D F Stern
Sep 5, 1998·JAMA : the Journal of the American Medical Association·Y XuG Casey
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·S l FuP K Vogt
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
May 15, 2001·Biochemical and Biophysical Research Communications·M HirataE Mekada
Sep 18, 2001·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·Y ItoN Matsuura
Jul 9, 2002·Biochemical and Biophysical Research Communications·C WallaschA Ullrich
Oct 29, 2002·Lancet·Richard E LeachD Randall Armant
Mar 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ryo IwamotoEisuke Mekada
Nov 5, 2003·The Journal of Cell Biology·Daisuke NanbaShigeki Higashiyama
Nov 5, 2003·The Journal of Cell Biology·Satoru YamazakiEisuke Mekada
Mar 5, 2004·Journal of Cell Science·Amar B SinghRaymond C Harris
May 29, 2004·Cancer Immunology, Immunotherapy : CII·Silvio BuzziFlavio Pironi
Jun 29, 2004·Seminars in Cancer Biology·Yaron Mosesson, Yosef Yarden
Jul 9, 2004·British Journal of Cancer·B F El-Rayes, P M LoRusso

❮ Previous
Next ❯

Citations

Mar 27, 2012·International Urology and Nephrology·Sabine Brandt, Peter R Mertens
May 8, 2009·Nature·Paula D BosJoan Massagué
Jul 25, 2008·The Journal of Biological Chemistry·Alejandra Pérez SastreMichael Schaefer
Aug 27, 2010·International Immunology·Claudio CostantiniMarco A Cassatella
Oct 7, 2011·Journal of Biochemistry·Kohei Miyazono
Oct 23, 2010·Current Opinion in Obstetrics & Gynecology·Hiroshi TsujiokaShingo Miyamoto
Apr 9, 2008·Journal of Pediatric Hematology/oncology·Masaharu AkiyamaHisashi Yamada
Feb 4, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·James YooEnrique Rozengurt
Feb 27, 2009·American Journal of Physiology. Renal Physiology·James P SmithRaymond C Harris
Feb 1, 2008·Molecular Cancer Research : MCR·Thomas E ReznikJohn Laterra
Apr 12, 2014·Molecular and Cellular Endocrinology·Gwenneg KerdivelGilles Flouriot
Oct 14, 2014·Expert Opinion on Therapeutic Targets·Anselmo PapaFederica Tomao
Oct 25, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kaoru NishikawaTetsuo Minamino
Feb 15, 2011·The Journal of Surgical Research·Rachel J Santora, Heitham T Hassoun
Oct 2, 2014·Archives of Toxicology·Mirjam M SchaapMirjam Luijten
Nov 9, 2007·Toxicon : Official Journal of the International Society on Toxinology·Jian QiaoManuel Caruso
Dec 3, 2008·International Journal of Cancer. Journal International Du Cancer·Hiroshi YagiShingo Miyamoto
Dec 12, 2007·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Seigo MinamiEisuke Mekada
Mar 15, 2016·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Ryo IwamotoEisuke Mekada
Sep 26, 2012·CNS Neuroscience & Therapeutics·Atsushi Oyagi, Hideaki Hara
Aug 14, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takayo TakemuraTetsuo Takehara
Jun 22, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Audrey ClapéronLaura Fouassier
Feb 11, 2014·International Journal of Cancer. Journal International Du Cancer·Soichiro SasakiNaofumi Mukaida
Jul 4, 2015·The Annals of Thoracic Surgery·Christopher W SederJeffrey A Borgia
Apr 20, 2016·Cancer Biotherapy & Radiopharmaceuticals·Caixia LianZhigang Tu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.